Master Alliance Provisions Guide (MAPGuide)

Fiocruz – AstraZeneca, COVID-19 Vaccine Technology Transfer Agreement

  • Equitable Access | Affordable pricing

<p><span style=”fontweight: 400;”>Whereas, in the face of the unprecedented challenges of the SARSCoV2 pandemic, the Parties have the following objectives (collectively referred to herein asthe Objectives”): span><span style=”fontweight: 400;”>[&#8230;]span>p>
<li><span style=”fontweight: 400;”>Make the Licensed Product available in the Territory at affordable prices in the country of use and use <a href=”#kt“>Best Effortsa> (as defined below) to ensure that Licensed Product pricing does not prevent the health authorities in any country from being able to obtain sufficient quantities of the Licensed Product to meet requirements in the country.span>li>